Reversible cystoid macular edema secondary to fingolimod in a renal transplant recipient.
Saab
Georges
G
Almony
Arghavan
A
Blinder
Kevin J
KJ
Schuessler
Rebecca
R
Brennan
Daniel C
DC
D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D000068876:Fingolimod Hydrochloride; D005451:Fluorescein Angiography; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation; D008269:Macular Edema / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology*; D011241:Prednisone / Q000627:therapeutic use; D011409:Propylene Glycols / Q000009:adverse effects*; D013110:Sphingosine / Q000009:adverse effects / Q000031:analogs & derivatives*; D041623:Tomography, Optical Coherence; D014184:Transplantation, Homologous
D007166:Immunosuppressive Agents; D011409:Propylene Glycols; D016572:Cyclosporine; D000068876:Fingolimod Hydrochloride; D013110:Sphingosine; D011241:Prednisone